跳至主要内容
临床试验/CTRI/2022/01/039218
CTRI/2022/01/039218招募中4 期

Assessment of visual performance of a new trifocal intraocular lens for visual quality and safety (Optiflex TRIO, Biotech Europe Meditech Inc. Ltd.)

BIOTECH EUROPE MEDITECH1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2022年10月1日最近更新:

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
100
试验地点
1
主要终点
2. quality of vision

研究概览

简要总结

This study is being conducted to evaluate the visual performance of a Trifocal Intraocular lens which has become recently available in India for correction of presbyopia after cataract extraction. The study is a post marketing clinical surveillance

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
40.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • Patient with bilateral age related senile cataract
  • grade of cataract permitting optical biometry
  • no ocular/systemic contraindication for surgery
  • a patient with preoperative corneal astigmatism less than 1D in each eye
  • normal macular functions with normal anantomy of macula as seen on optical coherence tomography
  • no history or evidence of ocular anatomical or functional disorders other than cataract including strabismus neuro-ophthalmological disorders of optic nerve or high visual functions corneal pathologies disorders of uvea vitreous pathologies retinal disorders
  • no systemic contraindications to surgery under local anaesthesia
  • patient willing to undergo the investigations and comply with the follow-up schedule.

排除标准

  • cataract precluding optical biometry
  • posterier-segment pathology
  • media opacity other than cataract
  • corneal higher order aberrations more than 0.3 micron as measured on ray-tracing wavefront aberrometer
  • patients with potential for intraoperative complications such as floppy iris syndrome and pseudo-exfoliation syndrome
  • cases where intra-operative complications compromise IOL placement with proper centration in the capsule bag
  • patient unwilling to undergo the required investigations or follow-up.

结局指标

主要结局

2. quality of vision

时间窗: 1. Pre-operative visit | 2. Operative visit | 3. Post-operative visit 1 - Day 1 | 4. Post-operative visit 2 - 1 month | 3. Post-operative visit 3 - 3 months | 3. Post-operative visit 4 - 6 months | 3. Post-operative visit 5 - 12 months

uncorrected and best corrected distance intermediate and near visual acuity

时间窗: 1. Pre-operative visit | 2. Operative visit | 3. Post-operative visit 1 - Day 1 | 4. Post-operative visit 2 - 1 month | 3. Post-operative visit 3 - 3 months | 3. Post-operative visit 4 - 6 months | 3. Post-operative visit 5 - 12 months

1. visual acuity

时间窗: 1. Pre-operative visit | 2. Operative visit | 3. Post-operative visit 1 - Day 1 | 4. Post-operative visit 2 - 1 month | 3. Post-operative visit 3 - 3 months | 3. Post-operative visit 4 - 6 months | 3. Post-operative visit 5 - 12 months

次要结局

未报告次要终点

研究者

发起方
BIOTECH EUROPE MEDITECH
申办方类型
Other [INTRAOCULAR IMPLANT MANUFACTURER]

研究点 (1)

Loading locations...

相似试验